Mice (8-10 weeks old) were subjected to a behavioral test battery. Essentially, tests were carried out as previously described (S4). A significant effect of genotype was identified in the acoustic startle response. Briefly, to measure acoustic startle response, mice were presented with 10 sound pulses of white noise at increasing decibel levels in individual startle chambers (Med Associates, VT, USA). The duration of each pulse was 40 ms with an interval between pulses of between 20 and 30 s. The startle response was recorded every millisecond for 65 ms after the onset of startle.
Tissue collection
Tissues were collected from +/+ and Afh/Afh mice at 3 hr intervals on the second day of constant darkness (DD) at circadian time (CT) 0, 3, 6, 9, 12, 15, 18 and 21, where CT12 corresponds to the onset of subjective night. For immunohistochemistry, mice were euthanized by pentobarbitone. Liver biopsies for protein and gene expression studies were taken prior to fixation for immunohistochemistry. For in situ hybridization, tissues were snap frozen in liquid nitrogen and maintained at -80 o C before processing.
Antibodies
Antibodies used for western blotting included β-actin as a loading control. An Fbxl3 polyclonal antibody was custom synthesized (Covalab) by immunizing rabbits with FBXL3-specific peptides LSSLKIDDTPVDDPS and DSAEEGTAEKPKRPR. The final bleed was affinity-purified using peptide affinity columns and used for western and immunohistochemistry (IHC) studies. S-tag HRP conjugate (Novagen) was used to detect CRY2. Additional primary antibodies are as described in (S5) . Secondary antibodies included goat polyclonal to rabbit IgG (Horseradish peroxidise, HRP) and goat polyclonal to mouse IgG (HRP) (Abcam).
Probes for in situ hybridization
Probes for Per1, Per2, Cry and Bmal1 were used previously described (S5) . A probe for Fbxl3 was generated by amplifying a 503 bp 3' UTR fragment and cloning into the pGEM-T Easy Vector (Promega). Antisense probes were generated using the T7 RNA polymerase. Primers for fragment amplification were GAACTGGAACATTTTAATAGGAA (forward primer) and AATAGTTGCCTTTAGTGTGGA (reverse primer).
Immunohistochemistry and in situ hybridization
Immunochemistry and in situ hybridization were carried out essentially as previously described (S5) .
Western blotting
Liver, lung and COS7 samples were lysed in RIPA buffer (50 mM Tris-Hcl pH7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS. 0.5% Sodium deoxycholate, 1 mM EDTA, 1 mM DTT, 50 mM NaF, 1 mM Sodium orthovanadate, 2 mM Glycerophosphate, 0.1 mM 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride (AESBF) , 1 complete protease inhibitor tablet (Roche) per 50 ml. Protein concentrations were determined using the Bradford protein assay (Sigma). Protein lysates were separated using NuPage Novex BisTris Gels (Invitrogen) following manufacturer's instructions and blotted onto polyvinylidene difluoride (PVDF) membrane (Amersham). Membranes were blocked overnight at 4 o C with 5% milk in PBS and incubated with primary and secondary antibodies for 1 hour and 2 hours, respectively, at room temperature. Relative densities were normalised against the loading control β-actin. Bands on autoradiographs were visualised using chemiluminescence and quantified with each background subtracted using densitometry analysis (Bio-Rad).
Real-time reverse-transcriptase (RT) polymerase-chain-reaction (PCR)
Gene expression in the liver was assessed using quantitative real-time PCR. After collection, samples of liver tissue were immediately stored in RNAlater (Ambion). Total RNA was extracted using an RNeasy Lipid tissue Mini Kit (Qiagen), according to the manufacturer's instructions, including an on-column RNase-free DNase step. RNA quantity and quality was assessed using an ND-1000 biospectrophotometer (NanoDrop Technologies). Total RNA (2µg) was reverse-transcribed with Superscript II enzyme, primed using random hexamers (Invitrogen). cDNA was PCR-amplified on an ABI SDS 7000 instrument (Applied Biosystems) using a qPCR SYBR Green I Kit (Eurogentec). Initially, for each gene, efficiency of amplification was determined over a 10 3 dilution of cDNA. The cDNA equivalent of 7.5ng of total RNA was then used to assess mRNA levels in all samples. In all cases reactions were performed in triplicate and averaged for analysis. Forward and reverse primers were as follows (all 5' to 3'): Cry1 forward: GCTATGCTCCTGGAGAGAACGT; Cry1 reverse: TGTCCCCGTGAGCATAGTGTAA; Fbxl3 forward: GAGCAGCTGTCCTCACGTCTCT; Fbxl3 reverse: GCCAGTTCTCGTAAGCCATGA; Per1 forward: CCCCTGCCTCCCAGTGA; Per1 reverse: CTGAAAGTGCATCCTGATTGGA; Dbp forward: GAGCCTTCTGCAGGGAAACA; Dbp reverse: GCCTTGCGCTCCTTTTCC; Actb forward: AGGTCATCACTATTGGCAACGA; Actb reverse: TGGATGCCACAGGATTCCAT Clock forward: TGTCTCAAGCTGCAAATTTACCA; Clock reverse: TTTAGATGCTGCATGGCTCCTA; Rev-erbα forward: CGTTCGCATCAATCGCAACC; Rev-erbα reverse: GATGTGGAGTAGGTGAGGTC. To prevent amplification of any residual genomic DNA, all primers or primer pairs were designed to span at least one intron. mRNA levels were determined by first calculating the ΔCT (difference in cycle threshold between the gene of interest and an internal control: Actb, β-actin). The lowest value (highest ΔCT) in a dataset was then subtracted from all other values to derive the change in level (ΔΔCT). Relative levels were then calculated using the formula 2
ΔΔCT which provides arbitrary unit values.
Bioluminescence recordings
All methods were carried out essentially as previously described (S6) .
Mammalian expression of GFP-tagged FBXL3
Full length wild-type or mutant FBXL3 cDNA was amplified using forward and reverse primers AAAATGAAACGAGGAGGAAGAGAT and GCCAAGTAGGCATCATGTCTGG. Amplified products were cloned into a CT-GFP fusion TOPO TA vector (Invitrogen). COS7 cells were transfected with either wild-type or mutant recombinant plasmid using the Polyfect transfection reagent (Qiagen).
Protein degradation studies
Real-time recordings of PER2::LUCIFERASE (PER2::LUC) expression from adult wildtype and homozygous lung tissue were recorded as previously described (S6) . At the peak level of PER2::LUC expression, cycloheximide (CHX) was added to the medium (20μg/ml) and tissue was collected after 0, 3, 5.5 and 8 hours of treatment. PER2::LUC levels were determined in real time after CHX treatment. Lung tissue was dipped 3x in icecold PBS and tissue samples were lysed and analysed by Western blotting. COS7 cells were cultured in DMEM (Gibco) supplemented with 10% fetal bovine serum. Cells were plated out into 6-well plates and each 35 mm dish transfected overnight with 0.3μg S-tag-mCry2 (pTriEx4, Novagen) and 0.5μg GFP-Fbxl3a (wt or Afh) using Genejuice (Novagen) according to the manufacturer's protocol. The following day CHX was added to a final concentration of 20μg/ml for 0, 2.5 and 5 hour incubations. Cells were lysed in 500μl RIPA buffer and analyzed by Western blotting.
Statistical analysis
Behavioral data were analyzed by ANOVA using the SPSS statistical package. Bonferroni correction was used to evaluate the probability of making at least one Type I error in multiple comparisons. Bioluminescence recordings were analysed by ANOVA with a posthoc Dunnetts t-test. A P-value of < 0.05 was considered statistically significant. Per-ir is reduced, particularly at CT9-15. The temporal profile for Cry-ir shows no apparent effect of genotype whereas that of Bmal1 is marginally reduced at CT18-21. Each value represents the mean + SEM for three animals. The panel on the bottom right shows representative photomicrographs of PER1-, PER2-, CRY1-and CRY2-ir in coronal SCN sections of +/+ and Afh/Afh mice at respective circadian peaks and troughs. Per-ir is dramatically reduced in Afh/Afh sections whereas CRY-ir shows no apparent effect of genotype, despite lower mRNA expression observed by in situ hybridisation. Table S1 . Comparison of circadian behavioral parameters in wild-type, Afh/+ and Afh/Afh mice. All parameters were measured using Clocklab software. Values represent mean + SEM (n=10 per group). LD, light-dark; DD, constant darkness. The period amplitude is measured in arbitrary units from power spectral analysis of time-series data. Levels of statistical significance are *P<0.01 and **P<0.001.
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